DFTX Definium Therapeutics, Inc.
Company Analysis
Latest News
🔴 Definium Therapeutics, Inc. is trading 4.4% down today as shares pull back after a multi-day run-up
Definium Therapeutics, Inc. is trading at $23.66 (4.4% down) as shares pull back following a multi-day run-up last week. • No fresh company-specific news,...
🟢 Definium Therapeutics, Inc. extends move to 5.6% up
DFTX is trading at $24.55, up 5.6% versus the comparison close of $23.24 during regular trading. This is a price-movement alert; no separate company-specific...
🟢 Definium Therapeutics, Inc. is trading 4.7% up today following institutional accumulation and sector momentum
Definium Therapeutics, Inc. is trading 4.7% up at $24.34, extending a multi-day rebound as the stock benefits from institutional accumulation and a broader...
🟢 Definium Therapeutics, Inc. is trading 4.8% up today amid broader biotech volatility and market sentiment
Definium Therapeutics, Inc. is trading at $24.05 (+4.79%) today, with the move appearing tied to broader market sentiment rather than a specific company...
🟢 Definium Therapeutics, Inc. is trading 5.71% up
DFTX is trading at $24.26, up 5.71%.
🔴 Definium Therapeutics, Inc. is trading 5.2% down today on broader risk-off sentiment ahead of U.S. CPI data
Definium Therapeutics, Inc. is trading 5.2% down at $21.75 in pre-market as broader risk-off sentiment pressures growth and therapeutics names ahead of key...
🔴 Definium Therapeutics, Inc. is trading 5.2% down today as rate fears and macro volatility weigh on growth stocks
Definium Therapeutics, Inc. is trading 5.2% down at $21.82 as the stock extends a multi-day pullback amid broader market weakness and higher-for-longer...
🔴 Definium Therapeutics, Inc. is trading 4.3% down today as macro worries extend multi-day pullback
Definium Therapeutics, Inc. is trading 4.3% down today at $22.02 as the stock extends a multi-day pullback amid broader macro and interest rate concerns. •...
🔴 Definium Therapeutics, Inc. is trading 5.6% down today on continued profit-taking and macro concerns
Definium Therapeutics, Inc. is trading 5.6% down at $22.23 as the stock undergoes a sharp two-day pullback following last week’s run-up and Friday’s...
🔴 Definium Therapeutics, Inc. is trading 5.1% down today as hot jobs data fuels interest rate concerns
Definium Therapeutics, Inc. is trading 5.1% down at $23.34 after a hotter-than-expected U.S. jobs report pushed interest rate expectations higher and pressured...
🔴 Definium Therapeutics, Inc. is trading 4.1% down today as strong U.S. jobs data fuels rate concerns
Definium Therapeutics, Inc. is trading 4.1% down at $23.58 today as a stronger-than-expected U.S. jobs report and rising interest rate expectations weigh on...
🟢 Definium Therapeutics, Inc. up 5% as investors anticipate key Phase 3 data
Definium Therapeutics, Inc. is trading at $24.78 (+5.04%) as investor anticipation builds ahead of key clinical trial results and following a positive...
🔴 Definium Therapeutics, Inc. is trading 6% down today as selling pressure persists following its Q1 2026 earnings miss
Definium Therapeutics, Inc. is trading 6% down at $22.61 as selling pressure persists following its recent Q1 2026 earnings miss and soft investor reaction. •...
🔴 Definium Therapeutics, Inc. is trading 6% down today as post-earnings weakness persists
Definium Therapeutics, Inc. is trading 6% down at $22.61 as the stock continues to face pressure following its Q1 2026 earnings disappointment. • The...
🔴 Definium Therapeutics, Inc. is trading 6.11% down
DFTX is trading at $22.59, down 6.11%.
🔴 Definium Therapeutics, Inc. is trading 4.8% down today as post-earnings weakness continues
Definium Therapeutics, Inc. is trading 4.8% down at $22.91, extending its decline following a disappointing Q1 2026 earnings report. • The company recently...